Akeso Shares Plunge 9.6% as Biotech Sector Faces Sell-Off – Key Factors & Outlook
Akeso’s shares plunge 9.6% amid sector‑wide sell‑off—discover how the biotech firm’s pipeline and future milestones could spark a rebound.
3 minutes to read
AKESO INC
Akeso Inc. (9926.HK) Gains 1.53% as New Phase II/III Trial for IVonescimab Launches
Akeso Inc. (HK: 9926) rises on a new Phase II/III trial for its bispecific antibody ivonescimab in biliary‑tract cancer, promising a survival edge over current therapies.
3 minutes to read